Skip to content
menu
简体中文
Home
About Us
Our Science
Pipeline
News & Events
Contact
News &
Events
news
4
June
2019
RemeGen, Ltd. Announces Positive Results from RC48 Clinical Trial in HER2 Positive Metastatic or Unresectable Urothelial Cancer
16
May
2019
RemeGen, Ltd. Highlights New Data to be Presented at 2019 American Society of Clinical Oncology (ASCO) Annual Meeting
Download latest presentation
For media inquiries, please contact Jennifer Gordon at
jgordon@spectrumscience.com